Manufacture

Richard Stedman from ACG Engineering outlines the trends driving change in the Indian pharmaceutical equipment industry.

Drug development needs to move more rapidly, but not at the expense of safety.

Is continuous manufacturing worth the investment for pharma companies?

New method to control polymorphism could see “widespread use across the pharma industry”.

Formulation fit for the future of complex molecules.

Newly published research suggests that some excipients may be more "active" than previously thought.

Single-use systems have come a long way. We look at experience with the technology so far.

Can a medieval medicament find use as a modern antibacterial?

We’re making progress on standardizing single-use systems – and it could mean a more cost-effective supply chain.

Gene therapy manufacturers will need to focus on upstream filtration to minimize the risk of viral infection.